Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Cemvita Factory Inc. has 6 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 6 distinct examiners and 5 distinct art units, showing broad examiner distribution with some art-unit overlap.
BREEN, KIMBERLY CATHERINE is the busiest examiner, with 1 pending action. Portfolio management should combine examiner-specific response planning with review of recurring technical issues within the shared art-unit assignments.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (17%) |
| §103 only | 2 (33%) |
| Multi-statute (no §101) | 3 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BREEN, KIMBERLY CATHERINE | 1 | 23.8% | +56.3% |
| LACLAIR, LOGAN EDWARD | 1 | 77.7% | +23.2% |
| RAGHU, GANAPATHIRAM | 1 | 73.7% | +26.5% |
| NGUYEN, HENRY H | 1 | 63.5% | +36.7% |
| KIPOUROS, HOLLY MICHAELA | 1 | 69.8% | +21.3% |
| SPANGLER, JOSEPH RANKIN | 1 | 40.8% | +70.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18325786 | PRODUCT | RAGHU, GANAPATHIRAM | 58d overdue |
| 18618868 | PROCESS AND PLANT | BREEN, KIMBERLY CATHERINE | 62d |
| 18325614 | COMPOSITIONS | NGUYEN, HENRY H | — |
| 18312893 | PROCESS | KIPOUROS, HOLLY MICHAELA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18325786 | PRODUCT | RAGHU, GANAPATHIRAM | 58d overdue |
| 17418505 | BIOSYNTHETIC METHODS AND SYSTEMS FOR PRODUCING MONOSACCHARIDES | SPANGLER, JOSEPH RANKIN | 14d |
| 18618868 | PROCESS AND PLANT | BREEN, KIMBERLY CATHERINE | 62d |
| 18507658 | PROCESS | LACLAIR, LOGAN EDWARD | — |
| 18325614 | COMPOSITIONS | NGUYEN, HENRY H | — |
| 18312893 | PROCESS | KIPOUROS, HOLLY MICHAELA | — |
| Art Unit | Apps |
|---|---|
| 1656 | 2 |
| 1657 | 1 |
| 1736 | 1 |
| 1652 | 1 |
| 1799 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18618868 | PROCESS AND PLANT | BREEN, KIMBERLY CATHERINE | 1657 | §101§103§112Other | Final Rejection | 62d | Pending | Mar 27, 2024 |
| 18507658 | PROCESS | LACLAIR, LOGAN EDWARD | 1736 | §103 | Non-Final OA | — | Pending | Nov 13, 2023 |
| 18325786 | PRODUCT | RAGHU, GANAPATHIRAM | 1652 | §103§112 | Non-Final OA | 58d overdue | Pending | May 30, 2023 |
| 18325614 | COMPOSITIONS | NGUYEN, HENRY H | 1656 | §102§103§112 | Non-Final OA | — | Pending | May 30, 2023 |
| 18312893 | PROCESS | KIPOUROS, HOLLY MICHAELA | 1799 | §103§112 | Final Rejection | — | Pending | May 05, 2023 |
| 17418505 | BIOSYNTHETIC METHODS AND SYSTEMS FOR PRODUCING MONOSACCHARIDES | SPANGLER, JOSEPH RANKIN | 1656 | §103 | Final Rejection | 14d | Pending | Jun 25, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCemvita Factory Inc. has 6 pending office actions as of October 2026, spread across 5 art units and 6 examiners.
Kimberly Catherine Breen has the most, with 1 of Cemvita Factory Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
